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Summary 
The prevalence of type 2 diabetes is increasing dramatically and type 1 diabetes moderately 
both in Norway and globally. As a result, long-term diabetes-related complications are also 
likely to increase. One long-term complication of diabetes is diabetes-related foot ulcers, 
which represent challenges for the individual and for the health care system. Awareness is 
growing that more attention should be given to this condition. 
Aim: The main aim of this study was to obtain more knowledge about people with diabetes 
reporting a history of foot ulcer (HFU) in a large, unselected population sample in Norway. 
We wanted 1) to determine the proportion of self-reported foot ulcers that required more 
than 3 weeks to heal and investigate associated factors, 2) to examine preventive foot care 
practices for people with diabetes and identify factors associated with such ulcers, 3) to 
compare levels of anxiety and depression as well as psychological well-being and perceived 
health between people with diabetes with and without a history of foot ulcer and those who 
reported not having diabetes and 4) to estimate the mortality risk for people who reported a 
HFU, people with diabetes without a HFU and people without diabetes. 
Methods: The study used a cross-sectional design in Papers I–III and a prospective design 
in Paper IV. During 1995 to 1997, the second health survey was conducted in Nord-
Trøndelag County, Norway, the Nord-Trøndelag Health Study 2 (HUNT 2). Those who 
responded positively to the question, “Do you have or have you had diabetes?” were 
classified as having known diabetes (n = 1972) and were invited to participate in the diabetes 
substudy. Those responding affirmatively to the question “Have you had a foot ulcer that 
required more than 3 weeks to heal?” were classified as having a HFU (n = 155) and those 
responding negatively as having diabetes without a HFU (n= 1339). Some 63,632 
participants reported not having diabetes. Measures of sociodemographic, lifestyle and 
clinical factors were available as well as perceived health and several aspects of 
psychological distress such as symptoms of anxiety, depression and psychological well-
being. Participants with self-reported diabetes were well characterized with regard to their 
diabetes condition. All participants in HUNT 2 were followed for 10 years, with mortality as 
the end-point. 
 xi
Results: The overall proportion of people with diabetes reporting a HFU was 10.4% [95% 
confidence interval (CI) 8.8%–11.9%]. Significant correlates of a HFU were male gender 
[1.5 (1.03–2.2)], age older than 75 years [odds ratio (OR) 1.8, 95% CI (1.2–2.8)], taller than 
the median (men >175 cm, women >161cm) [1.9 (1.3–2.8)], using insulin [1.6 (1.1–2.4)], 
and the presence of macrovascular complications [1.8 (1.2–2.6)] (Paper I). 
Some 58.8% of people with diabetes without a HFU reported regular preventive foot care 
(Paper II). Almost 85% reported receiving regular clinical diabetes examinations, 31.7% 
reported regular foot inspection by health care personnel and 66.3% reported foot self-
inspection. In addition, participants’ reports of inspections by health care provider and their 
own inspections were strongly correlated (P < 0.001). Independent variables associated with 
reporting preventive foot care included female gender, long duration of diabetes (>10 years), 
insulin use and membership in the Norwegian Diabetes Association. Those who reported 
macrovascular complications were less likely to report regular preventive diabetes foot care.  
In Paper III, we reported that anxiety and depression symptoms did not differ between those 
with diabetes reporting a HFU and those with diabetes without a HFU or those without 
diabetes. Among those with diabetes, perceived health was significantly worse among those 
reporting a HFU while psychological well-being did not differ. Perceived health and 
psychological well-being were significantly poorer among those with a HFU than among 
those without diabetes. 
Participants who reported a HFU had an increased mortality rate compared with both the 
subjects who did not report diabetes (hazard ratio 2.29, 95% CI  1.82–2.88) and those who 
did report diabetes but not a HFU (hazard ratio 1.41, 95% CI 1.09–1.82). The excess risk 
persisted after adjusting for comorbidity and depression scores (Paper IV). 
Conclusions: Overall, among community-dwelling people with known diabetes, 1 out of 10 
reported a HFU. Characteristics associated with a HFU were male gender, age older than 75 
years, taller than the median for each sex, insulin use and the presence of macrovascular 
complications. The clinical picture among people with diabetes reporting a HFU was 
complex, with several complications appearing at the same time. A HFU was associated with 
poorer perceived health. However, among people with diabetes a HFU was not associated 
with more anxiety or depression symptoms or poorer psychological well-being. 
 xii
Reported regular preventive foot care practices were associated with female gender, insulin 
use and having had diabetes for more than 10 years. Those reporting macrovascular 
complications were less likely to report regular preventive diabetes foot care.  
The findings in this study reinforce previous evidence of a link between diabetic foot 
ulceration and increased risk of death and extend knowledge concerning excess mortality 
beyond what was previously known about people with foot ulcers attending specialist health 
care clinics. The excess mortality risk of approximately 40% was only partly explained by 
older age, sex (male), a higher percentage of glycosylated hemoglobin (HbA1c), current 
smoking, insulin use, microalbuminuria, cardiovascular disease and depression. 
Our findings indicate the importance of identifying and monitoring people with foot ulcers at 
an early stage. The findings suggest that systematically implementing evidence-based 
guidelines in diabetes care and foot care may be very important for those with a HFU, who 
are particularly susceptible to adverse outcomes.  
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1. Introduction and literature review 
The prevalence of type 2 diabetes is increasing dramatically and type 1 diabetes moderately 
in both Norway and globally [1, 2]. The prevalence for all age groups worldwide was 
projected to rise from 2.8% in 2000 to 4.4% in 2030. The total number of people who have 
diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The most 
important contributor to the rise in diabetes prevalence globally appears to be the increase in 
the proportion of old people. However, given the increasing prevalence of obesity, these 
figures probably underestimate the future diabetes prevalence [1]. In Norway, about 90,000 
to 120,000 people have been diagnosed with diabetes, and for each person diagnosed with 
diabetes an undiagnosed person is expected to have diabetes [3]. Norway has a high 
prevalence of type 1 diabetes [4, 5]. The prevalence of type 2 diabetes has also been 
increasing [6], and the latest data indicate that this increase will continue, particularly among 
men [7].  
Diabetes is a chronic illness requiring continual health care and patient self-management 
education to prevent the development of acute complications and reduce the risk of long-
term complications [8]. As the prevalence of diabetes increases, the prevalence of long-term 
diabetes-related complications is also likely to increase [9]. The ‘diabetic foot’ has been 
considered the “Cinderella” complication of diabetes care, and the International Diabetes 
Federation dedicated the year 2005 to foot care of people with diabetes in order to raise 
awareness of foot disease among people with diabetes. No large epidemiological studies on 
diabetes-related foot ulcers have been conducted in Norway. 
Diabetes-related foot ulcers represent challenges for the individual and for the health care 
system, as they increase the demand for specialized health care. Even though preventive 
strategies have been shown to be cost-effective [10], meeting this demand in the health care 
system remains an enormous challenge from the financial and workforce perspectives [11, 
12]. The rapid increase of people with diabetes requires having a solid epidemiological 
knowledge base and developing high-quality health care services and effective preventive 
strategies. Thus, the overall aim of this study was to gain more knowledge about people with 
diabetes who reported a history of foot ulcer (HFU) in a large, unselected population in 
Norway. Knowledge obtained from this study concerning preventing foot ulcers and the 
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mortality associated with a HFU may contribute to the future development of health care 
strategies that enhance the quality of care for people with diabetes.   
1.1 Diabetes and foot ulcers 
People with diabetes are more likely to develop foot ulcers than people without diabetes 
[13]. Moreover, a HFU or current ulceration is the most important risk factor for new 
ulceration [14]. People with diabetes fear foot ulceration, which represents a challenge for 
the health care system [15, 16]. Awareness is growing that more attention should be given to 
this condition [17].  
The International Consensus on the Diabetic Foot defined a diabetic foot ulcer as a full-
thickness wound below the ankle in a person with diabetes, irrespective of duration [18]. 
Several risk classification schemes have been developed to facilitate communication 
between health care providers and to help guide diabetic foot assessment and management 
decisions [19, 20]. The most commonly used classification system internationally is 
Wagner’s, which consists of five stages [21]. The University of Texas expanded this 
classification system with an additional four stages [22]; in the SAD (size (area and depth)) 
system, neuropathy has been added [19]. Finally, the International Working Group on the 
Diabetic Foot has developed a classification system (PEDIS) that has recently been 
restructured [23]. 
Neuropathy and ischemia most often lead to the development of the foot at risk, although 
ulcers may frequently occur as a consequence of an interaction between specific pathologies 
in the lower limb and environmental factors [19, 24-26]. Diabetic foot ulcers may be divided 
into two groups: neuropathic ulcers and neuroischemic ulcers, the crucial difference between 
them being the absence or presence of ischemia. The purely ischemic foot is rare. Peripheral 
neuropathy is the most important causal pathway leading to foot ulceration and often leads to 
sensory deficit with the loss of protective pain sensation. Ischemia, on the other hand, results 
from atherosclerotic peripheral vascular disease, which usually affects the distal vessels of 
the lower limb [19]. Infection can complicate any type of diabetic foot ulcer and is one of the 
most common causes of hospital admission among people with diabetes.  
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Foot ulceration presents a troubling picture [27]. One in every seven individuals with 
diabetes has a foot ulcer during their lifetime [12, 28], and it has recently been suggested that 
the lifetime risk of a person with diabetes developing a foot ulcer could be as high as 25% 
[25]. Foot ulcers precede about 85% of all diabetic lower-extremity amputations [29]. It is 
argued that the use of the term “diabetic foot ulcer” may be misleading, as diabetic foot 
ulceration is very heterogeneous, whereby several pathophysiological mechanisms may be 
involved [30]. 
Reported annual incidence rates (new onset) varied between 1.2% and 3.0% [12, 14, 31]. 
Among studies with community-based samples, a large study in the United Kingdom 
reported a 2.2% (291 of 6613) annual incidence of foot ulcers after two years for survivors 
[14]. In a study in the Netherlands, [31] the annual incidence of foot ulceration varied from 
1.2% to 3.0% (mean 2.1%, 95% confidence interval (CI) 1.52–2.28) during the 3-year study 
period. Incidence rates in two clinically based studies in the United States were 1.9% and 
2.2%, respectively [12, 32].  
During the past two decades, various studies have reported estimates of the prevalence of 
having a HFU. A cross-sectional community survey among people with type 1 and type 2 
diabetes reported that 7.4% (95% CI 5.8–9.0%) had past or present foot ulceration [13]. 
Another study from three districts in the United Kingdom reported that 5.3% of those with 
type 2 diabetes had past or present foot ulcers [33]. Further, in a primary care–based survey 
of patients with clinical diabetes, 12% reported previous foot ulceration in Trinidad and 
Tobago [34], while data analyzed from the 2000–2002 Behavioral Risk Factor Surveillance 
System showed that 11.8% of United States adults with diabetes reported foot ulcers that did 
not heal for more than 4 weeks [35]. Only 2.1% of people with type 2 diabetes reported a 
HFU in a cross-sectional study in Australia. 
In conclusion, although international evidence on the epidemiology of diabetic foot ulcers is 
growing, little is known about the extent of this diabetes-related complication in Norway.  
1.2 Risk factors associated with foot ulcers 
Prospective studies have found that neuropathy, deformity and previous HFU are important 
risk factors for foot ulceration [14, 36, 37]. Many studies have investigated other potential 
 4
risk factors such as old age, male gender, low education, duration of diabetes, poor glycemic 
control, renal disease or microalbuminuria, poor vision, poor footwear, cigarette smoking, 
social deprivation and isolation, but the results are inconclusive [13, 32, 33, 37-42]. Height 
and waist circumference have been associated with neuropathy, but the direct impact of 
height and waist circumference on foot ulceration has been more uncertain [41, 43, 44]. 
Studies have used various methods and study populations as well as different potential risk 
factors and have arrived at different conclusions in predicting complications. In addition, the 
risk of diabetic foot ulceration in community settings has been less thoroughly explored than 
in cohorts from hospital diabetes clinics and dedicated foot clinics [45]. 
Further, ethnicity has been reported to affect the prevalence of foot ulcer. Abbott et al. [46] 
found that foot ulceration is more common among Caucasians than among Asians of Indian 
subcontinent origin, while Lavery et al. [47] have shown that ulceration is more common 
among Hispanic-Americans and in Native Americans than in non-Hispanic whites.  
It was thus of interest to examine the factors associated with a HFU in relation to 
demographic characteristics, lifestyle factors, diabetes-specific variables and comorbidity in 
a large unselected population-based study in Norway.  
1.3 Anxiety, depression, psychological well-being and 
perceived health 
An overall aim of diabetes care in Norway is that people should be able to live a good life 
despite having diabetes. In recent years, interest has increased in subjective patient-reported 
outcomes as a supplement to objective measures in research. Several somatic diseases, such 
as diabetes, commonly coexist with anxiety and depression [48], and these mental disorders 
are often comorbid. This picture becomes even more complex, as evidence suggests a 
bidirectional association between depression and diabetes [49-51]. The comorbidity of major 
depression and anxiety disorders is often associated with barriers to seeking treatment and a 
greater chance of the recurrence of mental disorders [48, 52]. Among people with diabetes, 
anxiety, depression and low subjective well-being are suggested to be of concern because 
these conditions may negatively affect self-management, glycemic control and diabetes-
related complications [52-54]. However, whether a HFU is associated with more anxiety and 
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depression symptoms or with poorer psychological well-being is unclear. As perceived 
health is thought to reflect the severity of the underlying disease burden [55], reports of 
perceived health among people with a HFU may contribute to greater knowledge about 
associations between HFU and perceived health in everyday life. 
1.3.1 Anxiety  
Earlier studies that have investigated anxiety among people with diabetes have used various 
instruments and/or methods. In clinical research, anxiety disorders are normally assessed 
using structured or semistructured diagnostic interviews and are diagnosed according to the 
criteria specified in the International Classification of Diseases (ICD-10) [56], or the 
Diagnostic and statistical manual of mental disorders of the American Psychiatric 
Association (DSM-IV) [57], which are standard classifications of mental disorders. Studies 
using diagnostic interviews include only clinical cases that meet the required criteria. 
However, this method is not suitable for use at the population level. In health surveys and/or 
screening, the Hospital Anxiety and Depression Scale (HADS) has been recognized as a 
valid instrument for measuring anxiety and depression symptoms. Studies using this 
questionnaire also include subclinical cases that do not meet all required DSM-IV criteria 
(possible cases measured by HADS 8 and probable cases by HADS 11) [58-60].  
A systematic review estimated the prevalence of generalized anxiety disorders among people 
with diabetes to be 14% and that up to 40% had elevated symptoms of anxiety [61]. This 
review included all available studies before 2001. All studies, except one, were hospital 
based. A recent  study with a large sample of people with diabetes recruited from both 
hospital and primary care settings in Ireland reported a prevalence of anxiety symptoms of 
32% (measured by HADS 8) [60].  
The literature on anxiety among people with diabetes-related foot ulcers is limited. 
Ragnarson Tennvall & Apelqvist [62] reported that people with primary healed ulcers had 
less anxiety than those with current ulcers. Carrington et al. [63] did not find differences in 
anxiety symptoms between people with a diabetic foot ulcer, amputation and diabetic 
controls (n = 52) (HADS 8). However, complications of diabetes such as cardiovascular 
disease and retinopathy have been shown to be the most important predictors for more 
anxiety symptoms among people with diabetes [60, 64]. A meta-analysis showed an 
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association between hyperglycemia and anxiety (using diagnostic interview) in type 1 and 
type 2 diabetes [65]. 
Although studies from hospital-based settings may indicate an association between anxiety 
and diabetes-related complications, little was known about the prevalence of anxiety 
symptoms among people with diabetes and a HFU in community-based samples.  
1.3.2 Depression  
Depression is more prevalent among people with diabetes than among people without 
diabetes [66]. Depression is associated with outcomes such as poor glycemic control [67] 
and long-term complications [64, 68]. In the HUNT 2 population, Engum et al. [69] found 
that comorbid chronic diseases among people with diabetes were associated with depression 
in type 2 diabetes. This is in accordance with the results of Pouwer et al. [70], in which one 
of every five people with diabetes and comorbid disease had depression.  
Some evidence indicates that diabetes related foot ulceration is associated with depression. 
A prospective study that recruited patients from foot clinics showed that one third of those 
who had a diabetic foot ulcer for the first time had clinical depression [71]. In addition, 
Carrington et al. showed that people with chronic foot ulceration reported significantly more 
symptoms of depression than controls with diabetes who had never had foot ulcers 
(measured using HADS) [63]. Depressive symptoms are reported to be associated with 
impaired healing and the recurrence of ulcers among older people with type 2 diabetes [72].  
The associations between foot ulceration and depression may be bidirectional: either that 
difficulty associated with foot ulceration might result in elevated feelings of depression or 
that depression might result in reduced foot-self care and the development of a foot ulcer. 
However, among people with their first foot ulcer, Ismail et al. [71] found no difference 
between diabetes self-care scores among people who were depressed and not depressed. Lin 
et al. [73] also found no association between depression and poorer preventive foot self-care.  
Although evidence suggests an association between a current diabetic foot ulcer and a higher 
risk of depression, whether depression is a problem among those who have had a foot ulcer 
is less clear.  
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1.3.3 Psychological well-being 
Psychological well-being refers to individuals’ subjective evaluation of their lives. The 
construct usually embraces a cognitive component of life satisfaction and two affective 
components: the presence of positive affect and the absence of negative affect [74, 75]. Little 
is known about psychological well-being and a HFU. However, in quality of life 
measurements, psychological well-being is often addressed as one domain reflecting mental 
health, as in the SF-36 Health Survey [76, 77], a commonly used questionnaire for 
measuring the quality of life. In diabetes care, International Diabetes Federation clinical 
guidelines recommend assessing well-being and the psychological status of people with type 
2 diabetes by questioning or by using validated measures as part of ongoing care [78]. 
Literature reviews have reported that foot ulcers affect self-reported quality of life [79, 80]. 
Qualitative studies show that foot ulceration adversely affects all domains of the quality of 
life [15]. In quantitative studies, associations between a foot ulcer and mental health are less 
evident than those between a foot ulcer and physical health. Several studies have associated 
foot ulceration with reduced scores related to physical health but not mental health [81-83]. 
Only one recent study in Norway has shown that people with a current diabetic foot ulcer 
had poorer quality of life than controls with diabetes and the general population sample. In 
the above study, both mental health scores and physical health scores were reduced, with 
physical health scores showing the greatest reduction [84]. One prospective study evaluated 
how a chronic foot ulcer affected the physical and mental functioning of patients and their 
caregivers at three points in time (baseline and after 20 and 32 weeks) [85]. People with 
healed ulcers scored better physical and social functioning than those with persisting ulcers. 
Although the study showed no change in mental functioning among people whose ulcers had 
healed, the mental health functioning of the caregivers improved significantly. However, 
mental health scores at baseline were not compared with those of other people without a foot 
ulcer. Further research in a larger sample was needed to explore psychological well-being 
among persons with a HFU. 
1.3.4 Perceived health 
Perceived health reflects an individual’s subjective perception of health conditions [86, 87]. 
Many studies have found that perceived health better predicts morbidity than many objective 
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measures of health [55, 88-90]. In quality of life research, the SF-36 Health Survey uses 
perceived health as one of five areas forming the general health domain. Results from the 
World Health Surveys demonstrated that chronic illness such as diabetes affects perceived 
health and that people with diabetes generally rate their health as being poorer than people 
without diabetes [91]. Among people with diabetes, those with current foot ulcers reported 
poorer perceived health than those with healed ulcers [62], although limited research has 
been conducted among those who have had foot ulcers.  
In conclusion, the literature on the association between a HFU and psychological distress, 
and between a HFU and perceived health is limited. Comparing the results is difficult, as the 
above studies used different methods and/or questionnaires, making it unclear whether a 
HFU is associated with psychological distress. Quality of life research, however, more 
clearly demonstrates how a HFU affects physical health. The associations between a HFU 
and anxiety and depression symptoms, psychological well-being and perceived health 
therefore needed to be investigated in a large population-based study to obtain valuable 
knowledge concerning psychological distress and perceived health among people with 
diabetes and a HFU. 
1.4 A history of foot ulcer and risk of mortality  
Diabetes is the fifth leading cause of death globally [92]. Among those with diabetes most 
deaths are due to macrovascular and cerebrovascular disease, including ischemia and stroke 
[93]. Although all main complications of diabetes independently predict excess mortality 
among people with type 2 diabetes [94], relatively few prospective studies have followed 
people with diabetic foot ulcers with mortality as the end-point. Samples in these previous 
studies were drawn from hospitals, foot clinics or outpatient settings, even though a 
substantial proportion of people with foot ulcers are treated in primary care [12, 95-99]. 
Most of the studies followed the sample for a short term (1–5 years). Faglia et al. [95] 
assessed the overall survival of 115 subjects with diabetes hospitalized for foot ulceration at 
a foot care center from 1990 to 1993 and followed up for 6.5 years. However, these studies 
in specialized care showed mortality rates of about 50% at 5 years.    
 
Mortality in people with a foot ulcer has often been explained by the presence of comorbid 
conditions such as cardiocerebrovascular disease and nephropathy [29], because peripheral 
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arterial disease and microvascular sclerosis associated with diabetic foot ulceration reflect 
established arterial disease elsewhere in the body [98]. In the study of Ghanasassi et al. [98], 
only renal impairment was an independent predictor of mortality. Among people with 
established foot ulcers, increased mortality appears to be independent of factors increasing 
ulcer risk such as neuropathy and peripheral vascular disease [97]. Mental factors have 
provided prospective evidence, as Ismail et al. [71] found that depression was associated 
with mortality among people with their first diabetic foot ulcer. One third of people with 
their first diabetic foot ulcer had clinically significant depression, and this was associated 
with a threefold increased risk of death until 18 months later. Young et al. [100] 
demonstrated that introducing aggressive management of cardiovascular risk may explain 
improvements in survival rates. People who developed a foot ulcer between 1995 and 1999, 
and those who were diagnosed between 2001 and 2004 took part in the study of Young et al. 
Overall 5-year mortality declined from 48.0% in cohort 1 to 26.8% in cohort 2. 
 
A large population-based study among community-dwelling adults and older people was 
needed to examine the impact of a HFU on mortality. The advantage of HUNT 2 is that 
participants are well characterized regarding several variables, including cardiovascular 
disease, microalbuminuria and mental factors including depression. Information on mortality 
is registered at the Norwegian Cause of Death Registry and would allow for a follow-up 
study over 10 years. 
1.5 Preventive foot care 
Norwegian and international guidelines recommend an annual comprehensive foot 
examination and the provision of foot self-care education to everyone with diabetes and that 
people with high-risk foot conditions be examined more regularly [18, 101-103]. 
Recommendations are well established, and several reviews have indicated the importance 
of preventive strategies [17, 25, 42, 45, 104]. In clinical practice, patients and health care 
personnel should discuss problems that arise over time to provide adequate monitoring and 
to emphasize aspects of self-care. Many people cannot perform preventive foot care 
practices due to poor vision and reduced mobility. Regular contact between patients and 
providers is therefore important [42].  
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Despite clinical guidelines and a greater focus on foot complications in diabetes in recent 
years, studies have shown a gap between recommendations and practices [105-110]. Among 
people with and without previous lower-extremity complications, 27.2–51.0% had their feet 
examined by a health professional during the previous year. 
A Cochrane review summarized that patient education seemed to be positively influence foot 
care knowledge and the behaviour of patients in the short term [111, 112]. Gulliford & 
Mahabir [34] found that adequate foot care knowledge and health behaviour seemed 
important for seeking health care support. Evidence about the effect of educational 
interventions in preventing diabetes-related foot ulceration is inconclusive [112-115] and 
available studies often have poor methodological quality [111].  
In Norway, no large epidemiological study had examined preventive foot care practices and 
the characteristics of those receiving preventive care. Given the challenges associated with 
diabetes and foot ulcers for the individual and for society as a whole, establishing more data 
about preventive foot care was important for developing future health care strategies.   
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2. Aims and objectives of the present study  
The overall aim of this study was to obtain more knowledge about people with diabetes who 
reported a HFU in a large, unselected population in Norway. The study addresses 
epidemiological issues related to prevention and mortality by examining correlates 
associated with a HFU, exploring preventive foot care practices, assessing psychological 
distress and estimating the mortality rate ratios of a HFU. 
 
The more specific aims were as follows. 
Paper I: 
• To determine the proportion of self-reported foot ulcers that required more than 3 
weeks to heal in a population-based sample of people with diabetes and to investigate 
factors associated with such ulcers. 
Paper II: 
• To examine preventive foot care practices among people with diabetes in the Nord-
Trøndelag Health Study and to identify associated demographic, lifestyle and 
disease-related factors. 
Paper III: 
• To compare levels of anxiety and depression symptoms, as well as psychological 
well-being and perceived health between 1) people with diabetes who reported a 
HFU, 2) people with diabetes without a HFU, and 3) people without diabetes.  
• If differences were found, to examine whether these could be explained by 
demographic characteristics, lifestyle factors and cardiovascular disease status in 
addition to diabetes-specific variables.  
Paper IV: 
• To estimate the mortality risk for those reporting a HFU compared to those without a 
HFU and the non-diabetic population, after adjustment for other known risk factors 
for mortality. 
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3. Material and methods 
3.1 Nord-Trøndelag County 
Nord-Trøndelag County is one of Norway’s 19 counties and is located in central Norway. In 
1995, Norway’s population was about 4.48 million and Nord-Trøndelag’s population was 
about 127,500. The size of this rural county is 22,463 km2 [116]. This area is ethnically 
homogeneous, with only 3% Sami or other people of non-Caucasian origin, and with 
migration of 0.3% per year (1996–2000). The average income and the prevalence of higher 
education and of current smokers are slightly lower than the national average. The county 
has two hospitals and 24 municipalities but lacks a large urban area. In 1995, the biggest 
town was Steinkjer, with a population of about 21,000 people. However, Nord-Trøndelag 
County is fairly representative of Norway as a whole in relation to age distribution, 
morbidity, mortality, economy, sources of income and the stability of its population, making 
it suitable for epidemiological purposes. 
 
3.2 The second Nord-Trøndelag Health Study (HUNT 2)  
The second Nord-Trøndelag Health Study (HUNT 2) was performed from 1995 to 1997. A 
personal invitation was sent to all inhabitants 20 years or older (n= 92,434) [116] inviting 
them to participate in the study. The invitation included a questionnaire (Q1, Appendix I) 
and a suggested time and place for a clinical examination. A five-member screening team 
and a bus with office and laboratory facilities visited the 19 smallest communities, while a 
stationary team stayed for several months in each of the five largest towns. Specially trained 
nurses and technicians carried out this fieldwork, which lasted 2 years. At the medical 
examination performed at the screening stations, a second questionnaire (Q2) and third 
questionnaire (Q3) were handed out (Appendixes 2 and 3). Four versions of Q2 were used 
depending on age and sex, and Q3 had three different versions delivered to those with self-
reported diabetes, asthma or lung diseases or hypertension in Q1. Those answering yes to 
diabetes in Q1 were included in the diabetes substudy. Table 1 presents an overview over 
key elements of HUNT 2 used in the papers in this dissertation.
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 The questionnaires: Q1 included questions stating present or previous diabetes, myocardial 
infarction, angina pectoris, stroke and smoking. In addition, the status of physical activity, 
education, perceived health, life satisfaction, anxiety and depression (HADS) was solicited. 
The national personal identification number applied includes the date of birth (used to 
calculate age at attendance) and sex. Q2 incorporated, among others, questions related to 
psychological well-being. Q3-diabetes consisted of two pages concerning diagnosis, 
treatment, disease duration, HFU and amputation, preventive foot strategies and membership 
in the Norwegian Diabetes Association. The participants were asked to complete Q2 and Q3 
and return them by mail using a pre-stamped addressed envelope. As a result of this 
procedure, data are missing more frequently for Q2 and Q3 than for Q1.  
 
The brief clinical examination included measurements of height, weight and waist 
circumference. Height was measured without shoes to the nearest centimeter, and weight 
was measured to the nearest 0.5 kilogram while wearing light clothing without shoes. Waist 
circumference was measured at the umbilical level in centimeters. Reported blood pressure 
readings are the mean of the second and third of three systolic and diastolic readings using a 
Dinamap 845 XT (Critikon) blood pressure device based on oscillometry. Blood sampling 
was carried out whenever subjects attended (in the non-fasting state). This non-fasting serum 
sample was analyzed for glucose for all participants in HUNT 2. For those who reported 
diabetes (Q1), an extra tube of whole blood was drawn to analyze HbA1c. Those confirming 
diabetes were also reinvited to another blood sampling in the fasting state a few days later 
for classification of diabetes. 
 
Participants reporting diabetes were included in screening for microalbuminuria. When they 
attended the clinical examination, they received a unit with three tubes for three repeated 
first-morning urine samples and one pre-stamped envelope to return the samples by mail to 
the laboratory. Written instructions were enclosed in the unit. The urine samples were 
analyzed for albumin and creatinine [116]. According to recommendations for people with 
diabetes, microalbuminuria was defined as an albumin-creatinine ratio >2.5 mg/mmol [117, 
118]. To minimize day-to day variation, microalbuminuria had to be present in at least two 
of three urine samples. 
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About 3 weeks after the examination, every participant received a personal letter from the 
HUNT Research Centre containing the results of the measurements and, if necessary, advice 
on lifestyle and necessary follow-up. Participants with abnormal clinical or biochemical 
values were advised to visit their general practitioner. 
 
A follow-up appointment was given to participants reporting known diabetes. A fasting 
blood sample was drawn and was mailed to the Laboratory of Clinical Chemistry at 
Levanger Hospital, located in the County. Samples were analyzed for glucose, C-peptide and 
GAD antibodies (74.8% participation) to differentiate between type 1 and type 2 diabetes 
[116]. Diabetes was categorized as type 1 diabetes (insulin treatment started within 6 months 
after diabetes diagnosis and either as: anti-GAD 0.08 units or anti-GAD <0.08 and/or C-
peptide <150 pmol/l), or type 2 diabetes (treated with diet only or oral antidiabetic 
medication or commencement of insulin treatment 12 months or more after the diabetes 
diagnosis and anti-GAD <0.08 units). At the new appointment, seven participants reported 
having had gestational diabetes during a previous pregnancy and did not have diabetes. They 
were excluded. As recommended by the World Health Organization [119], people with 
latent autoimmune diabetes of adults (LADA) were combined with those classified as having 
type 1 diabetes.  
3.3 Study samples 
This study includes different study samples defined by different questions. Fig. 1 shows the 
study design of HUNT 2 and how the sample was derived for Papers I–IV (boxes with a 
thick line). Papers I, II and III were descriptive, cross-sectional studies; Paper IV was a 
prospective study. Table 2 shows the study samples used in Papers I–IV. Complementary 
information regarding the proportion of HFU, preventive foot care questions, anxiety and 
depression (HADS), psychological well-being, perceived health and the follow-up study is 
given below. 
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Fig. 1 Sample derivation  
 
The participation rate was 71%. Participants were defined as those who returned Q1 or 
attended the brief clinical examination.  
Additional diabetes questionnaire (Q3) 
n = 1,692 
Question: “Have you had a foot ulcer 
that required more than 3 weeks to 
heal?”      n =1,494 
HFU;  
n=155 
Attended: n = 65,604 
Self-reported diabetes    
n = 1,972 
Completed questions 
about clinical diabetes 
examination and foot 
inspection  
n = 1,459
No HFU;  
n =1,339 
Analysis sample for 
preventive strategies 
without a HFU 
n = 1,312 
HFU;  
n = 147 
Gestational diabetes  
n = 7
Not self-reported diabetes  
 n = 63,632 
 
Question: ‘‘Do you have or have you had diabetes? 
Invited: n = 92,434 
(eligible) 
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Table 2. Study samples used in Papers I–IV 
 Paper I Paper II Paper III Paper IV 
n = 63,632   X X 
n = 1,339 X  X X 
n = 155 X  X X 
n = 1,312  X   
 
3.3.1 Proportion with a history of foot ulcer 
A total of 1972 participants answered the question “Do you have or have you had diabetes?”. 
Those answering affirmatively were invited to take part in the diabetes substudy. The 
definition of a HFU was based on the question: “Have you had a foot ulcer that required 
more than 3 weeks to heal?” (Q3). Those answering yes were included in the sample (n = 
155) and those responding no as having diabetes without a HFU (n = 1339). Persons 
answering affirmatively but reporting that they had had a foot ulcer for less than 3 weeks 
were excluded from the foot ulcer sample and coded as not having had a foot ulcer for more 
than 3 weeks (n = 7).  
3.3.2 Preventive foot care questions 
Preventive foot care practices were examined among people with diabetes but without a 
HFU. This was done to avoid combining examinations for prevention of foot complications 
with follow-up examinations of the sample.  
 
Two central elements of the prevention of foot complications were combined, as they are 
essential for quality care [120]. These were defined as including both:  
(a) regular clinical diabetes examination involving physical examination by a physician, 
nurse or other health care personnel; and   
(b) regular foot inspection, either by health care personnel or by people themselves (Table 
3). 
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Table 3. Questions used to define prevention of foot complication 
Elements of the prevention of 
foot complications 
Related questions 
Regular clinical diabetes 
examination involving physical 
examination by a physician, nurse, 
or other health care personnel 
“Do you see a doctor for regular check-ups for your diabetes?” (yes, no) 
‘‘If not, do you see a nurse or other health care personnel for check-ups 
for your diabetes?’’ (yes, no) 
 
Regular foot inspection, either by 
health care personnel or self-
inspection 
 
“Are your feet examined regularly by any of the following?” (yes, no) 
- Doctor 
- Podiatrist 
- Nurse or  home care nurse 
- Other 
- Yourself 
 See Appendix 3 for diabetes questionnaire Q3. 
3.3.3 The Hospital Anxiety and Depression Scale 
Zigmond & Snaith developed HADS [121] to assess anxiety and depression symptoms. 
HADS emphasizes the mental signs or consequences of anxiety and depression. HADS 
consists of 14 items. The seven questions in the anxiety subscale (HADS-A) are related to 
generalized anxiety but also address fear or panic. The seven questions in the depression 
subscale (HADS-D) are based on the concept of anhedonia (the absence of positive affect 
and pleasure from everyday tasks [121]). Five questions refer to reduced pleasure. 
Anhedonia is central to the concept of depression [122, 123]. Scores range from 0 to 21 for 
each subscale; higher scores represent more distress. The cut-off points for severity in 
anxiety and depression are: 0–7, normal; 8–10, mild; 11–14, moderate; and 15–21, severe 
[123]. Bjelland et al. [58] reported that 8 for both the anxiety and depression subscales 
represented the optimal cut-off point  This study presents descriptive values continuously; 
cut-off points of 8 and above and 11 and above are shown. The HADS is well validated [58]. 
Previous factor analysis of HADS in HUNT has been shown to result in a two-factor 
solution consistent with the two subscales of anxiety and depression [124]. Regarding 
internal consistency, Cronbach’s alpha values for the anxiety and depression subscales in 
HUNT were 0.80 and 0.76 respectively [124].  
3.3.4 Psychological well-being and perceived health 
The concept of psychological well-being is used to assess whether people with a HFU report 
poorer psychological well-being (mood) than comparisons groups. The psychological well-
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being index used in the study was constructed using a sum score of four items, covering life 
satisfaction, vigor, calmness and cheerfulness (Table 4); a higher score indicates a higher 
level of well-being. These questions have been used as single questions [125] and as a scale 
[75, 126]. We preferred to use a scale as opposed to single questions, because this reduces 
random error. One question was located in Q1 and the other three in Q2. Regarding 
reliability, Cronbach’s alpha and inter-item correlation were measured for the psychological 
well-being index.  
Cronbach’s alpha for the psychological well-being index was 0.81, and inter-item 
correlations ranged from 0.47 to 0.60. Principal component analysis of the four items was 
performed and yields a clear unidimensional solution, which is an assumption for combining 
questions into one single scale.  
Table 4. Psychological well-being scale.  
Item 
“Considering how you feel these days, are you generally satisfied with your life, or are you generally dissatisfied?” 
“At present, do you mostly feel strong and fit or tired and worn out?” 
“Do you by and large feel calm and good about yourself?” 
“Would you say you are usually cheerful or dejected?” 
See Appendixes1 (Q1) and 2 (Q2) 
Perceived health was measured using the following item: “How is your health these days?”  
(measured on a scale from 1 = poor to 4 = very good). We cannot measure the reliability of 
one single item, but several studies have used this single item measure of perceived health 
and highly similar versions, which have been shown to have acceptable psychometric 
properties [88]. The question concerning perceived health was placed in Q1. 
3.3.5 Follow-up 
In the follow-up study, we estimated mortality rates for people with diabetes with and 
without a HFU and for the people without diabetes. All participants were followed for 10 
years- with mortality as the end point. Information on main causes of death was obtained by 
linking individual data to the Norwegian Cause of Death Registry using the unique 11-digit 
–personal identification number assigned to each resident of Norway.  
Mortality data with mortality diagnosis were obtained from the Norwegian Cause of Death 
Registry. Mortality diagnoses are coded according to the International Classification of 
Diseases (10th revision) and were categorized into diseases as follows: diabetes mellitus 
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(E10–E14), ischemic heart disease (I20–I25), cerebrovascular disease (I60–I69), other 
circulatory diseases (I00–I15, I26–I28, I30–I52, I70–I79, I80–I99), renal disease (N00–
N39), cancer (C) and other diseases: certain infectious and parasitic diseases, diseases of the 
musculoskeletal system and connective tissue, diseases of the genitourinary system, 
congenital malformations; deformations and chromosomal abnormalities; other endocrine, 
nutritional and metabolic diseases; ill-defined causes of violent deaths; and sudden death of 
unknown cause (A, B, D, E00–E07, E15–E90, F–H, J–M, N40–N99, O–Y).  
3.4 Model of the variables investigated 
The model in Fig. 3 provides an overview of associations between variables investigated and 
HFU. The associations investigated that are presented in Papers I–IV are indicated by the 
numbers I, II, III and IV, respectively, in an effort to operationalize the objectives of this 
study. 
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4. Data analysis and statistical methods  
4.1 Data analysis and covariates 
The covariates included in the final analyses of Papers I–IV were selected due to either 
rationale in the literature, preliminary analysis or statistical limitations. The section below 
gives an overview of the covariates used.   
 
Sociodemographic factors 
Age was defined as the age of the participants on the day of attendance in HUNT 2. In the 
logistic regression models, age was represented with dummy variables (indicator variables), 
as age and outcome (HFU or preventive foot care) were not linearly related. In Paper I, age 
was dichotomized as less than 75 years versus 75 years or more. In Paper II, age was 
categorized as less than 65 years, 65–74 years and 75 years or more. In Papers III and IV, 
age was used continuously.  
Education: The questionnaire provided five categories for education. Education was 
categorized as education less than10 years versus 10 years or more (Papers III and IV) [69]. 
Paper IV included a separate category for missing cases.  
Marital status was dichotomized as single or alone (unmarried, widowed, divorced or 
separated) versus not single or alone (married or cohabiting) (Paper II).  
Height was dichotomized at the median for each sex (men >175 cm, women >161 cm) 
(Paper I). 
 
Lifestyle factors 
Waist circumference was dichotomized as men 102 cm and women 88 cm (Papers I, II 
and IV) [127].  
Body mass index (BMI) was calculated as kilograms per m2 (Paper III).  
Current smoking (yes/no) was dichotomized (Papers I–IV).  
In relation to diabetes self-education the question was: “Are you a member of the Norwegian 
Diabetes Association?” (yes/no) was used (Paper II).  
 
Clinical factors 
Duration of diabetes was dichotomized as less than 10 years versus 10 years or more [101].  
 23
HbA1c was categorized as HbA1c <7.5%; 7.5–9.0%; >9.0% in Paper II [128]; and used 
continuously in Papers III and IV.  
Insulin use (used/did not use). Those who did not answer but reported that they used tablets 
to regulate their diabetes were coded as “did not use” (Papers I–IV).  
Hypertension was defined as blood pressure of 140/90 mmHg or more or as current use of 
antihypertensive drugs (Paper IV) [129]. 
 
Complications were defined as microvascular complications (microalbuminuria, self-
reported eye problems due to diabetes) or macrovascular complications (history of stroke, 
myocardial infarction, angina pectoris and peripheral vascular surgery) (Papers I and II).  
Cardiovascular disease was defined as being present in those who responded positively to 
one or more of the following items: a history of angina pectoris, myocardial infarction and 
stroke (Papers III and IV).  
 
Mental health 
Hospital Anxiety and Depression Scale depression scores (HADS-D 8) were used as a 
covariate (Paper IV). 
 
4.2 Statistical methods 
Statistical analysis was conducted using SPSS version 13.0, 14.0 and 15 (SPSS Inc., 
Chicago, IL, USA). Statistical significance was assessed with two-sided P < 0.05. Several 
types of statistical analysis were used depending on the research questions and the variables.  
 
Descriptive analysis 
Descriptive statistics (mean, standard deviation and percentages) were calculated for 
subgroups of diabetes, demographic, lifestyle and disease-related variables and variables 
related to health care settings, diabetes examination, foot inspection and psychological 
assessment (Papers I, II and III). Cronbach’s Alpha was used to determine the internal 
consistency reliability of the psychological well-being scale and HADS (Paper III). 
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Simple comparisons 
T-tests were used to compare mean values, chi-square tests for proportions and Mann-
Whitney tests for median values between people with diabetes with and without a HFU and 
people without diabetes (Papers I, III and IV). In bivariate analysis chi-square tests were 
used to compare variables by subgroups defined by type of examination, (a) regular foot 
inspection by health care personnel, (b) regular foot self-inspection or (c) regular monitoring 
(regular clinical diabetes examination combined with regular foot inspection by a health care 
provider or regular foot self-inspection) (Paper II). Chi-square tests were used to determine 
whether the outcome measures of the regular inspection by health care personnel of 
respondents’ feet and regular self-inspection were related (Paper II). 
 
Multivariate analyses 
Logistic regression analysis: Logistic regression was used to generate odds ratios for 
independent correlates that were associated with the binary outcomes, a HFU (Paper I) and 
preventive foot care (Paper II). Increasingly complex models were developed by adding one 
set of variables at a time. For bivariate and multivariate models, odds ratios (OR) and 95% 
CI are reported (Paper II). 
 
Univariate multiple linear regression analysis: In Paper III, the four continuous variables 
symptom levels of anxiety (HADS-A) and depression (HADS-D), psychological well-being 
and perceived health were transformed to z-scores (variables with a mean of zero and a 
standard deviation of 1), to facilitate comparisons of effects (mean differences) between 
subgroups across outcomes.   
 
The three participant subgroups were used as an independent categorical variable, entered in 
the univariate multiple regression analysis as two dummy variables with the subgroup 
without diabetes as reference. In separate univariate multiple regression analyses of the two 
diabetes subgroups, those without a HFU were used as the reference group.  
 
Cox proportional hazards regression analysis: In Paper IV, Cox proportional hazards 
regression analysis was used to estimate mortality rate ratios (hazard ratios) and 95% CI 
from the date of inclusion in the study (1995–1997) to December 31, 2005. We created 
dummy variables for the people with diabetes without a HFU and those with a HFU such 
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that the hazard ratio for each category represents the comparison of that category to the non-
diabetic population.  
Preliminary, simple Cox regression analysis was performed to examine the association 
between all baseline covariates and all-cause mortality. For covariates with more than 2% 
missing data in the foot ulcer group, we included missing cases for education (n = 16), waist 
circumference (n = 5), microalbuminuria (n = 10) and depression (n = 11); separate 
“unknown” categories were used.  
 
Multiple Cox proportional hazard regression analyses were then performed to estimate 
mortality rate ratios (hazard ratios) and 95% CI. Analysis was performed with adjustment for 
other known risk factors for mortality. Covariates were organized thematically in blocks, and 
increasingly complex models were developed by adding one set of variables at a time using 
forced entry. Variable selection in multivariable modelling was carried out a priori based on 
previous knowledge and assessment of the variable in relation to time, cause and effect.  
 
We performed some separate additional analyses to explore whether this would alter results: 
1) we excluded those with a history of amputation; and 2) we included diabetes classification 
and diabetes duration in Cox regression analysis (Paper IV).  
 
Survival curves  
Kaplan-Meier survival curves were calculated to describe the all-cause mortality in the 
subgroups (Paper IV).  
 
Power calculations 
In Paper IV, power calculations were performed before study start. Analysis showed a 
statistical power of 78% to detect an increased risk of 33% among the foot ulcer group 
compared with the population with diabetes without a HFU and assuming a mortality of 30% 
during follow-up in this group. 
 
Collinearity 
Collinearity for the final models (Papers I and II) was assessed using the condition index 
[130]. 
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Statistical interaction 
In separate models, the presence of statistical interaction (effect modification) was tested by 
adding multiplicative terms involving the sample subgroups variable to the full regression 
model while retaining each of the other independent variables. Interaction terms were tested 
for one pair of variables at a time (Paper III). Also, in Paper IV, separate Cox regression 
analyses were performed to test for possible interactions between the main exposure (non-
diabetic subjects and diabetic subjects with and without a HFU) and the other covariates in 
the model among people with diabetes. 
 
Table 5. Statistical tests used in Papers I–IV 
 
Statistical methods used 
 
Paper I Paper II Paper III Paper IV 
 
Descriptive statistics 
 
 
x 
 
x 
 
x 
 
x 
T-tests 
 
x x x x 
Chi-square tests 
 
x x x x 
Mann-Whitney tests 
 
x x x x 
Logistic regression analysis 
 
x x   
Univariate multiple regression analysis 
 
  x  
Cox proportional hazards regression analysis 
 
   x 
Power calculations 
 
   x 
Survival curves  
 
   x 
Condition index 
 
x x   
Tests for possible effect modification 
 
  x x 
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5. Ethical and legal issues  
The Norwegian Data Inspectorate and the Regional Committee for Medical Research Ethics 
approved the HUNT 2 study. All information in HUNT is treated according to the guidelines 
of the Data Inspectorate [116].  
Participation in this study was voluntary, and each participant signed a form giving informed 
consent to participate in the screening, brief examination and follow-up, and allowing the 
use of data and blood samples for research purposes. Participants also consented to linking 
their data to other registries. After data were collected, the HUNT Research Centre removed 
all names and personal identification numbers before further research was conducted [116]. 
This study therefore complies with the Declaration of Helsinki. The HUNT Research Centre 
was responsible for ensuring that all the ethical formalities associated with the study were in 
order. Thus, we used existing data and did not have contact with the participants. 
In substudy IV, we applied for approval from the Central Norway Regional Committee for 
Medical Research Ethics, and the HUNT Research Centre to 1) merge the data from the foot 
ulcer study related to HUNT 2 with information about death in the years 1997–2007 (Cause 
of Death Registry) and 2) analyze mortality in a 10-year follow-up of people reporting a 
diabetic foot ulcer in HUNT 2 (1995–1997) and those who did not. We also requested 
information on death during 1997–2007 from the Norwegian Cause of Death Registry. 
Information on main causes of death and date of death was obtained by linking individual 
data to the Cause of Death Registry using the unique 11-digit personal identification number 
assigned to each resident of Norway. The HUNT Research Centre did this. 
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6. Summary of results 
6.1 Paper I 
History of and factors associated with diabetic foot ulcers in Norway: the Nord-
Trøndelag Health Study 
Marjolein M. Iversen, Kristian Midthjell, Truls Østbye, Grethe S. Tell, Elizabeth Clipp, 
Richard Sloane, Monica W. Nortvedt, Sverre Uhlving & Berit R. Hanestad 
Scandinavian Journal of Public Health, 2008; 36: 62–68. 
The aim was to describe the proportion of people with diabetes with a HFU and to examine 
factors associated with a HFU. The overall proportion with a HFU was 10.4% [95% CI: 
8.8%–11.9%]. Table 6 shows the sample with diabetes and a HFU stratified by age and sex. 
 
Table 6. The sample with diabetes and a HFU stratified by age and sex 
 
Age (years) Men  Women Total 
 n %  n % n % 
        
<50 11 12.5  11 16.4 22 14.2 
50–64 19 21.6  10 14.9 29 18,7 
65–74 25 28.4  17 25.4 42 27.1 
75–84 32 36.4  23 34.3 55 35.5 
85 + 1 1.1  6 9.0 7 4.5 
 88 100.0  67 100.0 155 100.0 
 
Those reporting a HFU were asked about how many weeks the ulcers took to heal (reported 
in weeks; if several times, the time that lasted the longest). The response rate was 71.6% 
among those with a HFU. Thirty percent of the foot ulcers required more than 16 weeks to 
heal. The median healing time was 8 weeks (range 4–220). 
In bivariate analyses among those with diabetes, height, waist circumference, less than 1 
hour of physical activity per week, HbA1c, insulin treatment, duration of diabetes, self-
reported stroke, peripheral vascular surgery, any lower limb amputation, microalbuminuria 
and eye problems related to diabetes were associated with a HFU. Finally, in multivariate 
analysis, significant correlates of a HFU were male gender [OR 1.5, 95% CI: 1.03–2.2], age 
older than 75 years [OR 1.8, 95% CI: 1.2–2.8], height above the median (men >175 cm, 
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women >161cm) [OR 1.9, 95% CI: 1.3–2.8], using insulin [OR 1.6, 95% CI: 1.1–2.4], and 
presence of macrovascular complications [OR 1.8, 95% CI: 1.2–2.6].  
 
The relationships between age, height, waist circumference, duration and a HFU were not 
linear. Nevertheless we repeated the last model including age, height, waist circumference 
and duration as continuous variables. For height, waist circumference (measured in cm) and 
duration (measured in years), we received rather similar results to the main results presented 
in the paper, with OR of 1.047, 1.016 and 1.015 respectively. This corresponds to an OR of 
1.58 for a difference of 10 cm of height and an OR of 1.17 for a difference of 10 cm in waist 
circumference and an OR of 1.16 for a difference of 10 years of duration. However, for age 
the effect disappeared, reflecting the nonlinear relationship. There was a threshold, effect 
with marked increased risk for people older than 75 years but no relationship between the 
outcome and age for the group of people younger than 75 years. We decided to keep the 
model with the dichotomized variables since these odds ratios might be easier to interpret in 
clinical practice. 
 
6.2 Paper II 
Regularity of preventive foot care in persons with diabetes: results From the Nord-
Trøndelag Health Study 
Marjolein M. Iversen, Truls Østbye, Elizabeth Clipp, Kristian Midthjell, Sverre Uhlving, 
Marit Graue, Berit R. Hanestad  
Research in Nursing and Health, 2008; 31: 226–237. 
Since regular foot inspection by health care providers and by people themselves is a primary 
aspect of prevention, we wanted to explore the regularity of preventive foot care practices 
and to assess the characteristics of those getting preventive foot care and those not. To 
separate examinations for prevention of foot complications from follow-up examinations of 
those who already might have foot ulcers, we included only those with known diabetes but 
without a HFU (n=1312).  
Among these 1312 persons, 58.8% reported regular preventive foot care. Almost 85% 
reported receiving regular clinical diabetes examinations, but only 31.7% reported regular 
foot inspection by health care personnel and 66.3% reported foot self-inspection. In addition, 
 30
participants’ reports of health care provider inspections was strongly related with their own 
inspections (P < 0.001). 
Independent variables associated with getting preventive foot care were: female gender, long 
diabetes duration (>10 years), using insulin and being a member of the Norwegian Diabetes 
Association. Those who reported macrovascular complications were less likely to receive 
regular preventive diabetes foot care.  
6.3 Paper III 
The association between history of diabetic foot ulcer, perceived health and 
psychological distress: the Nord-Trøndelag Health Study. 
Marjolein M. Iversen, Kristian Midthjell, Grethe S. Tell, Torbjørn Moum, Truls Østbye, 
Monica W. Nortvedt, Sverre Uhlving, Berit R. Hanestad.  
BMC Endocr Disord, 2009, 9:18. 
 
The purpose of this study was to obtain more knowledge regarding psychological distress 
and perceived health associated with a HFU. The mean depression score was significantly 
higher among people with a HFU than among people without diabetes (4.7 versus 3.5). The 
proportions scoring 8 and above were 18.8% for those with a HFU and 10.8% for those 
without diabetes (P = 0.002). The percentages scoring 11 or more were 7.6% for those with 
a HFU and 3.2% for those without diabetes (P = 0.002). However, in multivariate analyses 
we found that anxiety and depression symptoms did not differ for those with a HFU 
compared with whether those without diabetes or those with diabetes but without a HFU.  
 
Perceived health and psychological well-being were significantly poorer among those with a 
HFU than among those without diabetes. Within the diabetes groups we found that perceived 
health was significantly worse among those reporting a HFU, but psychological well-being 
did not differ. 
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6.4 Paper IV 
A history of foot ulcer increases mortality among persons with diabetes: 10-year 
follow-up of the Nord-Trøndelag Health Study, Norway.  
Marjolein M. Iversen, Grethe S. Tell, Trond Riise, Berit R. Hanestad, Truls Østbye, Marit 
Graue, Kristian Midthjell. 
Diabetes Care, 32:2193–2199, 2009. 
We intended to examine the relationship between a HFU and subsequent 10-year registry-
assessed mortality. The main findings were that the subjects who reported a HFU 
experienced increased mortality compared with both the subjects who did not report diabetes 
[hazard ratio 2.29, 95% CI: 1.82–2.88] and the subjects who reported diabetes but not a HFU 
[hazard ratio 1.41, 95% CI: 1.09–1.82].  
The excess risk persisted after adjusting for comorbidity and depression scores. Table 7 
provides characteristics at entry (baseline) for the subgroups by whether they died during the 
follow-up period. Table 8 shows the distribution of main causes of death by subgroups 
(“diabetes with a HFU”, “diabetes without a HFU” and “non-diabetes”). 
In separate analyses including people with HFU only, the estimated effects of HbA1c, insulin 
use, microalbuminuria and depression scores increased. The estimated effect of HbA1c was 
slightly stronger, although it was not significant due to the low number [hazard ratio 1.11; 
95% CI: 0.97–1.28]. The estimated effects of insulin use [hazard ratio 2.13; 95% CI: 1.16–
3.90], microalbuminuria (hazard ratio 2.77; 95% CI: 1.54–4.98] and depression scores 
[hazard ratio 1.93; 95% CI: 1.03–3.64] were significant associated with mortality. However, 
the estimated effects of older age, sex (male), current smoking and cardiovascular disease 
decreased and were not significantly associated with mortality. 
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7. Discussion 
The aim of this study was to gain more knowledge about people with diabetes reporting a 
HFU in a large, unselected population in Norway. This study, which is a substudy of HUNT 
2, is the largest population-based study ever conducted on foot ulcers among people with 
diabetes. Our study is also the first investigating a HFU and the associated risk of mortality 
among community-dwelling persons. This section considers the methodological strengths 
and limitations and the extent to which bias and confounding may have influenced the 
results of the study. There is also a discussion of the main findings.  
7.1 Methodological considerations 
7.1.1 Study design 
Our study designs reported in Papers I–III were cross-sectional: measuring the associations 
between various factors and either a HFU (Paper I) or receiving preventive foot care (Paper 
II) and the association between a HFU, perceived health and psychological distress (Paper 
III). In these cross-sectional designs, measurements of the various factors were determined 
approximately at the same point in time. The study reported in Paper IV used a prospective 
design with baseline factors as predictors of mortality over a 10-year period in the three 
study groups: people with diabetes with and without a HFU and people without diabetes.  
The cross-sectional design is especially appropriate for describing associations between 
variables at a fixed point in time [131]. The most important limitation of a cross-sectional 
study is that conclusions regarding causality cannot be drawn. In the prospective design, we 
started out with a presumed cause and followed the cohort forward in time to observe the 
effect, allowing inferences, although cautiously, regarding cause and effect.  
7.1.2 Selection bias and representativeness 
Selection bias is systematic error resulting from the procedures used to select subjects and 
from factors that influence study participation [132] and is present when factors related to 
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the outcome (such as a HFU) differ between the participants and nonparticipants. Selection 
bias can never be corrected by statistical analyses. 
Among those eligible, about 70% participated in HUNT 2. The nonparticipants were 
compared with HUNT 2 participants in a separate study, which revealed that a larger 
proportion of nonparticipants older than 70 years had health problems than participants of 
the same age [116], which suggests some selection bias. 
In the current study, we had to deal with missing answers on selected questions or 
questionnaires. Among the 1972 persons reporting diabetes in HUNT 2, 1692 returned Q3 
and 280 did not. Among those who returned Q3, 198 did not answer the question: “Have you 
had a foot ulcer that required more than 3 weeks to heal?” (Fig. 1). We compared 
characteristics between participants and nonparticipants in the missing groups. A larger 
proportion of nonparticipants had unfavorable lifestyle characteristics, had suffered a stroke 
and had depressive symptoms. Hence, our study population probably had better physical and 
mental health than the nonrespondents. Selection bias may have resulted in an 
underestimation of the number of people with a HFU, as discussed in Paper I. In the sample 
reporting preventive foot care (Paper II), those with a HFU were excluded. Selection bias 
would thus only occur in this sample if factors associated with preventive strategies differed 
between participants and nonparticipants.  
An underrepresentation of individuals with more severe illness may have resulted in weaker 
observed effects, such as the association between depressive symptoms and a HFU. 
Although a higher proportion of people with a HFU may have declined to participate 
compared to people without a HFU, this should not have affected the validity of the results 
presented in Papers II, III and IV.   
Generalizability means the degree to which the results of a study may apply to, be relevant 
for, or be generalized to populations or population groups outside the study [133]. The 
population sample in this study is not fully comparable to the general population in Norway, 
as Nord-Trøndelag lacks a large urban area, and the average income, the prevalence of 
higher education and the prevalence of current smokers are slightly lower than the national 
average. Nevertheless, we have no reason to believe that the proportion having a HFU 
differs much among Caucasians in Norway, even though factors such as insulin use, 
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microalbuminuria, HbA1c and depression scores influence the excess mortality associated 
with a HFU. 
The prevalence of foot ulcer may differ between various ethnic groups [46, 47]. Thus, 
because our study sample is ethnically homogeneous, our results may not be applicable to 
other ethnic groups.  
The data from HUNT 2 were collected 10 years ago, and this may reduce the relevance of 
the study (Papers I–III). However, the proportion of people reporting regular preventive foot 
care and the proportion reporting a HFU are still relevant in current practice, as national 
guidelines regarding foot care practices have not changed during the past 10 years [103, 128, 
134]. Concordant with our findings, preliminary results from community-based cross-
sectional studies carried out in Norway in 1995 [108, 135], 2000, and 2006 [135] have also 
shown that foot care practices have not improved over these years.  
7.1.3 Information bias 
Information bias results from errors concerning information received from or about subjects 
in a study, leading to incorrect measurements of exposure or outcome [132]. Incorrect 
information or incorrectly measured variables may lead to misclassification; this bias may 
result in systematic error in the estimation of effect.  
Self-report bias 
Health care personnel did not verify people’s HFU, and people may have incorrectly 
reported HFU status, which might have contributed to misclassification. Although asking 
people with diabetes to self-report a HFU has inherent limitations, clinically validating the 
diagnosis by clinical data or by interview in this large epidemiological study was not 
feasible. A group of clinical experts discussed the diagnostic cut-off time for an ulcer. The 3-
week timeline was considered a natural cut-off, because when ulcers need more than 3 
weeks to heal, they are more likely to be directly related to the underlying diabetic condition. 
Even though some participants may erroneously have reported other types of ulcers, such as 
venous leg ulcers, the term foot ulcer (fotsår) is probably less ambiguous in Norwegian than 
it is in English. 
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HUNT 2 included validated questionnaires where possible. Section 3.3.3 discusses the 
reliability and validity of HADS, the psychological well-being scale and perceived health.  
Information on demographics, lifestyle and prevalent disease was collected using 
questionnaires. Almost all questions had some missing values. Missing values were recoded 
as ‘no’ for the questions on diabetes, stroke, myocardial infarction, angina pectoris and 
problem with eyes due to diabetes (Q1) and for amputated legs/toes (Q3). The rationale for 
this was that we assumed that people do not forget such significant events in their lives. Due 
to sampling procedures, data were missing more frequently for variables located in Q2 than 
Q1 (three of four questions in the psychological well-being scale were located in Q2) (Paper 
III). We performed missing substitution for individuals not answering one or two questions 
in HADS-A or HADS-D according to standard procedures for the HADS questionnaire [121, 
136] . We did not alter missing values on other questions. One consequence of this was that 
information on physical activity, with 22,5% missing values, could not be included in the 
multivariate analyses. In Paper IV, for covariates with more than 2% missing data in the foot 
ulcer group, separate “unknown” categories were used. This involved education (n = 16), 
waist circumference (n = 5), microalbuminuria (n = 10), and depression (n = 11).  
Self-reported diabetes was validated by blood tests. Midthjell et al. [137] reported that using 
this self-administered questionnaire to determine diabetes diagnosis provided reasonably 
accurate information about diabetes mellitus, as a substudy revealed that diabetes was 
verified in 163 out of 169. Nevertheless, some subjects with diabetes were probably 
misclassified as not having diabetes. Including an unknown number of subjects with diabetes 
in the non-diabetes group at baseline may have influenced the results. Among the people 
without known diabetes, 62,757 delivered a non-fasting venous blood sample for glucose 
measurement. Of these, 217 had a non-fasting glucose concentration exceeding 11 mmol/l 
but were included in the non-diabetes group. Including these cases in the non-diabetic group 
did not influence the mortality risk estimate. However, the self-reported question about 
diabetes probably underestimated the number of subjects with diabetes, and if these 217 
persons were diagnosed as having diabetes they would have constituted a considerable part 
of the diabetes group. 
Approximately 25% of the participants with diabetes were not classified with regard to type 
of diabetes because they failed to attend the follow-up appointment in a fasting state. For 
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some, the invitation for a follow-up appointment was sent during the summer holidays, and 
thus missed some participants. The proportions of type 1 and type 2 diabetes should, 
therefore, be viewed with caution. Because of missing information regarding the 
classification of type 1 and type 2 diabetes, this variable was not included in the multivariate 
analyses.  
Urine samples 
Microalbuminuria was measured in those who delivered three urine samples (individuals 
with diabetes and hypertension). The attendance rate was high (almost 90%), minimizing 
selection bias [138]. In previous studies, the threshold for microalbuminuria has varied from 
2.5 to 3.5 mg/mmol for men and women [118]. In this study, we used a cut-off of 2.5 
mg/mmol for both sexes based on previous studies [117, 118, 138]. However, since women 
have less muscle mass and excrete less creatinine in urine than men, a higher cut-off value 
for women has also been recommended [117]. This study might therefore overestimate the 
proportion of women with microalbuminuria and the results should be considered with 
caution. 
Follow-up 
As the incidence of type 2 diabetes is increasing dramatically and type 1 diabetes 
moderately, new cases of diabetes most likely occurred in the non-diabetes group during the 
follow-up period. However, the only information we have for subjects without diabetes 
during the follow-up period is that 0.5% of deaths in this group were diabetes-related. 
7.1.4 Confounding 
Confounding means that the estimated effect of the exposure is mixed together with the 
effect of another factor [132]. There are three criteria for a confounding factor: it must be a 
risk factor for the disease; it must be associated with the exposure being studied in the 
source population; and it should not be an intermediate step in the causal pathway between 
the exposure and the disease. Further, the confounder should not be an effect of the exposure 
or the outcome.  
Observational studies use stratification or various multivariate statistical techniques such as 
multivariate regression models to reduce the effect of confounding. The challenge is to 
identify whether a factor is actually a confounder or not. Age and sex are well-known 
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confounders in the association between exposure and outcome, and are therefore often 
adjusted for in multivariate analyses. Separate analyses revealed that age was a confounder 
in the association between a foot ulcer and mortality. Factors related to lifestyle, such as 
current smoking, waist circumference or BMI, are often associated with exposures under 
investigation and various diseases or health problems. In this study, we therefore adjusted 
for these variables in multivariate analyses. However, if a factor is an intermediate step in 
the causal pathway between the exposure and the disease it is considered as mediating the 
effect of the exposure. Hence, because amputation is most likely an effect of a HFU, we did 
not adjust for this variable. On the other hand, comorbidity such as microalbuminuria or 
having had a myocardial infarction, stroke or angina can be potential mediators and may act 
as intermediate variables as well as confounders. The covariates in Paper IV, however, did 
not markedly change the estimates of the association between a HFU and mortality.  
Higher HbA1c, insulin use and longer duration of diabetes are related to the severity of 
diabetes, and are considered risk factors for a HFU. In regression analyses among those with 
diabetes, with and without a HFU, we considered these variables as covariates. In Paper I, 
we only included duration and insulin use in the multivariate model due to limited degrees of 
freedom and information in the literature [36, 41, 107]. In Paper IV, we included HbA1c and 
insulin use based on information in the literature [71, 100, 139].  
In Paper IV, we included the HADS-scores as covariates in multiple Cox proportional 
hazards regression analyses with mortality as the outcome. In Paper III, however, we 
considered a HFU, lifestyle factors, clinical factors and comorbidity as covariates 
(confounders) and adjusted for them in the regression analyses, as psychological distress 
(HADS-A, HADS-D, psychological well-being and perceived health) might be a 
consequence of a HFU, rather than the cause. 
7.2 Main discussion  
7.2.1 Diabetes and a history of foot ulcer 
In this study, 10.4% of those with diabetes reported a HFU. Other studies have reported that 
between 2.1% and 12% of those with diabetes have current or previous foot ulceration. Two 
 40
previous studies conducted in primary health care settings, one from the Trinidad and 
Tobago [34] and the other from the United States [35], reported quite similar proportions. 
However, the results of the latter study, the Behavioral Risk Factor Surveillance System 
[35], should be considered with caution due to methodological weaknesses. This was a 
random-digit-dialing telephone survey conducted in 50 states, but the response rate was only 
48.9%, the number of people participating was not reported and people without telephones 
were not included [35]. Compared with the Trinidad and Tobago study [34], we would 
expect to find a higher proportion of HFU in our study as other reports have emphasized the 
role of ethnicity in the onset of foot ulcers [46]. It has previously been suggested that height 
may serve as a proxy for ethnicity but also for childhood socioeconomic status [140]. In our 
study, height was positively associated with a HFU. The previous proposed explanation of 
the link between height and neuropathy (neuropathy is often present in the foot at risk) is 
that height is also associated with the length of axons, and longer axons are more prone to 
metabolic disturbances [41, 141]. As Norwegians are relatively tall and may have a higher 
risk of neuropathy, this may contribute to a higher prevalence of foot ulcers. However, the 
very fact that Norway has a comprehensive health care system, with closer medical follow-
up of diabetes patients, may account for a lower proportion of HFU among Norwegians with 
diabetes. In any case, we found that a HFU is a relatively common problem among 
community-dwelling people with diabetes, as 1 out of 10 with diabetes reported having had 
a foot ulcer. Due to potential selection bias, our estimates of the proportion of people with 
diabetes who currently have or have had a HFU are probably conservative. 
7.2.2 Psychological distress and perceived health 
The results presented in Paper III do not support an association between a HFU and 
depression in this population-based sample of people with diabetes. Psychological distress 
such as depression seems to be more pronounced when people have a current foot ulcer [71]. 
Nevertheless, depressive symptoms are reported to be associated with impaired healing and 
recurrence of ulcers in older people with type 2 diabetes [72]. However, our results 
presented in Paper IV support an increased risk of mortality among people with a HFU who 
also have depressive symptoms, in accordance with Ismail et al. [71]. Systematic monitoring 
and treatment of depression among those with a HFU and those at risk of developing a 
diabetes-related foot ulcer, should therefore be considered [139].  
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Studies estimate the prevalence of anxiety disorders in general population samples as 
ranging from 13% to 17% [142, 143]. The prevalence of anxiety measured by HADS 
(subscore  8) in HUNT 2 was about 15% [124, 144]. Results from various studies are 
difficult to compare as different study designs, samples and/or different questionnaires have 
been used. Methodological differences create difficulty in comparing these study results 
[145]. In our study, however, the prevalence of anxiety symptoms in the diabetes groups 
with and without a HFU did not differ from that of the general population, and more specific 
ways to measure diabetes-related anxiety, such as fear of hypoglycemia, may be needed. 
A HFU had an independent impact on perceived health in addition to the underlying diabetes 
illness itself, indicating more severe diabetes (Paper III). The fact that a foot ulcer is likely to 
indicate more severe disease has become clearer during recent years [40, 100, 146], and our 
results showed that simply having had a foot ulcer influences perceived health, suggesting 
that advanced diabetes influences perceived health in everyday life. Hence, a HFU was 
associated with poorer perceived health, no association was found between a HFU and more 
psychological distress. This may indicate that a HFU is more the result of biological factors 
rather than mental ones. The clinical picture of people who have had diabetes for a long time 
is complex, with several complications appearing at the same time, perhaps affecting their 
ability to self-manage their diabetes. Focusing on perceived health may help to identify 
vulnerable people with diabetes and to offer them more intensive, individual support and an 
appropriate foot care program. 
7.2.3 Importance of preventing of foot ulcers  
This large population-based cohort study examined the relationship between a HFU and 
subsequent 10-year risk of mortality. The increased mortality risk was about 40% at 10 years 
among those with a HFU compared to those without a HFU. Previous studies from 
specialized care show an increased mortality rate of about 50% at 5 years for people with 
foot ulceration compared to those with diabetes without foot ulceration [12, 95-98]. The 
present results reinforce previous evidence of a link between foot ulceration in diabetes and 
risk of death and extend knowledge concerning excess mortality to a community-wide 
population sample in Norway.  
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In HUNT 2, the diabetes groups did not differ statistically in mortality rates due to 
cardiovascular disease, although people with a HFU had a higher prevalence of 
cardiovascular disease and more cardiovascular risk factors at baseline than those without a 
HFU. A possible explanation for this may be that only the main cause of death was included 
and that cardiovascular disease and the cardiovascular risk factors may have contributed to 
death, but not been the main cause for some cases in the HFU group.  
The risk of foot ulceration among community-dwelling people with diabetes has been 
investigated less than foot ulceration in hospital diabetes clinics and dedicated foot clinics 
[45]. As we included the general diabetes population in our study, we also included those 
with previous foot ulcers that have healed without encountering the health care system. As a 
group, the persons with diabetes who reported a HFU are expected to have less severe 
diabetes than hospital-based samples. In our study, the median healing time for previous 
ulcers was 8 weeks (range 4–220). The median time for healing foot ulcers in a recent cohort 
study among people with diabetes treated in a multidisciplinary foot center in Sweden was 
18 weeks (range 1–235) [40]. These findings lend support to the assumption that diabetes is 
more severe among people attending hospital and foot care clinics, as opposed to among 
community-based samples.  
Although people with diabetes-related foot ulcers in this sample seemed to have less severe 
diabetes than those in hospital settings, early identification of foot ulcers and intensified 
treatment at an early stage seem to be important. Systematic implementation of evidence-
based guidelines seems particularly important for those with a HFU, who are susceptible to 
adverse outcomes. One out of 10 diabetic participants in our study had a foot ulcer, and this 
subgroup had excess mortality. During 2003–2004, a large multicenter study in Europe 
collected data on foot ulcers, characteristics, health care organization and clinical outcomes 
in 14 foot ulcer centers. Twenty-seven percent of the people with foot ulcers had been 
treated for more than 3 months before being referred to a foot clinic [30, 147]. Prompers et 
al. [30] reported that the severity of diabetes-related foot ulcers at presentation was greater 
than previously reported; the treatment that many people received was not in accordance 
with current guidelines, and countries and centers differed widely. These results complement 
the results of our study and underscore the fact that promoting the prevention of foot ulcers 
in diabetes care needs greater emphasis. 
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Compared to women, a higher proportion of men reported a HFU [14, 40, 148]; and men 
were also less likely to get regular preventive foot care [149]. Among all persons with 
diabetes, men had higher mortality rates than women, however this was not seen in the HFU 
subgroup. Different explanations have been proposed for the observed higher risk in men, 
including genetic differences, hormonal factors protecting women from vascular 
comorbidity, and differences in life expectancy [40]. Further, sex differences in mean body 
height have been proposed as an explanation, as longer nerve fibers are thought to be more 
prone to metabolic disturbances and to influence the development of peripheral neuropathy 
[41, 150].  
Aggressive treatment has shown to have favourable effects on mortality among people with 
a diabetes-related foot ulcer [100]. However, with regard to sex differences, reports from 
European registries show that women with diabetes are treated less frequently with 
aggressive medical treatment such as aspirin, angiotensin-converting enzyme (ACE) 
inhibitors, beta-blockers and revascularization therapy than men [151-153].  
The results of our study indicate that men are more likely to report a HFU than women, and 
men were less likely to report regular preventive diabetes foot care. Within diabetes foot 
care, the focus on biological explanations has been greater than on behavioral explanations. 
Concerning behavioral aspects, however, it has been reported that men express fear of the 
future, show a passive attitude and mobilize their social networks to obtain additional care, 
whereas women are more prone to use preventive measures and are more active in self-care 
than men [149]. This complements and is in accordance with our results and suggests that 
health care workers need to use different approaches in educating men in foot self-care than 
in educating women. 
The results from a recent posttrial report from the United Kingdom Prospective Diabetes 
Study found that better glycemic control at the beginning of the trial was associated with 
reduced risk of myocardial infarction and death from any cause after a 10-year follow-up 
[154]. Further, Young et al. [100] showed that implementing a systematic and aggressive 
strategy for managing cardiovascular risk improved survival among those with diabetes-
related foot ulcers. In our study, a 1 percentage point increase in HbA1c was associated with 
a 7% increase in the risk for all-cause mortality after 10 years. More than half of our study 
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participants with type 2 diabetes had HbA1c values exceeding 8.0%, indicating the clinical 
relevance of this finding.  
People with diabetes and chronic foot ulcers often have cardiovascular disease [155, 156]. 
Also, those reporting macrovascular complications were less likely to report regular 
preventive diabetes foot care. The 2009 Norwegian recommendations [134] and the current 
American Diabetes Association recommendations [8] indicate that peripheral vascular 
disease is a risk factor, but do not list cardiovascular disease as a characteristic of people at 
risk of a HFU. Physicians, diabetes nurses and nurses in coronary care units need therefore 
to be aware that people with diabetes and heart disease may be particular vulnerable to foot 
ulcers and that early implemention of preventive foot care strategies is of utmost importance. 
The results from a foot clinic study in Scotland [100] indicated that implementing a more 
systematic and aggressive strategy for managing cardiovascular risk improved survival 
among those with diabetes-related foot ulcers. Further, a study of primary care patients in 
Norway showed substantial improvements in the quality of care among those with type 2 
diabetes, and this improvement was related to better outcomes, including improved HbA1c, 
systolic blood pressure, cholesterol, and 10-year risk of coronary heart disease [157]. 
Follow-up studies from HUNT 1 and HUNT 2 have also shown a general reduction in 
mortality rates from cardiovascular disease [129]. Although those with diabetes benefited 
from the overall decline in mortality, the more than twofold higher mortality rate from 
cardiovascular disease associated with diabetes persisted over time. Thus, systematically 
implementing of evidence-based guidelines in diabetes care and foot care is very important 
for those with a HFU who are particularly susceptible to adverse outcomes. 
7.3 Implications for clinical practice 
The following implications may be drawn from this study. 
• Foot ulcers appear to be a marker of more severe illness, not only among people with 
diabetes in specialist care but also for those in primary care. A greater focus on foot 
care among people with diabetes in primary health care is therefore needed. Close 
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follow-up in primary health care also appears to be important for those with a minor 
foot ulcer that seems to be healing well. 
• Health care personnel in primary health care (home care, nursing homes and general 
practitioners’ offices) need to promote the prevention of foot ulcers among people 
with diabetes. Those who are at risk of foot ulcers or have foot ulcers need to be 
followed-up closely.  
• Men were more likely to report a HFU than women. However, men were less likely 
to report regular preventive diabetes foot care. Health care workers may need to 
employ different approaches in the education of men in foot self-care than those used 
for women. 
• Cardiovascular disease is often prevalent among people with diabetes and chronic 
foot ulcers. Health care personnel in diabetes care and coronary care need to be 
aware that people with diabetes and heart disease are more vulnerable to developing 
foot ulcers.  
• The clinical picture of people with HFU and long diabetes duration is often complex, 
with several complications affecting their ability to self-manage. Systematic 
screening of perceived health and depression among people with a HFU should be 
considered. 
• The increasing prevalence of diabetes is also likely to increase long-term diabetes-
related complications. Diabetes foot care in Norway may need to be organized more 
efficiently.  
• Greater emphasis needs to be placed on applying national guidelines in diabetes foot 
care in Norway.  
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7.4 Implications for future studies 
The results of this study encourage further research in different areas.  
Determining whether primary preventive foot care strategies can make a difference. Future 
studies should follow up the samples described in Paper II and examine whether those 
reporting regular preventive care and those who did not in HUNT 2 (Paper II) differ in the 
onset of a foot ulcer in HUNT 3 (conducted in 2006-2008). Such a prospective study can 
determine whether primary preventive foot care strategies can make a difference. Statistical 
probability needs to be explored a priori to determine whether a 10-year follow-up with this 
sample size will have enough power to detect differences.  
 
Estimating the prevalence and incidence of HFU. Health care personnel did not verify a 
HFU in our study. Norway is in the early stages of establishing a population-based registry 
of people with diabetes (adults). Having reliable data on foot ulcers enables both the 
prevalence and the incidence of this diabetes-related complication to be estimated accurately 
in Norway and will minimise misclassification of a HFU. Further, the longitudinal data 
above will enable the illness trajectory of those with diabetes to be mapped during their 
lifetime and the foot ulceration process to be monitored, including both current and healed 
foot ulcers.  
Monitoring and reporting on the standard of quality of foot care in Norway. A nationwide 
follow-up of registry data in primary health care is needed in order to monitor the 
identification of foot ulcers and their treatment at an early stage. Several examples in 
Norway, and elsewhere show that equal conditions are treated unequally [158]. Studies using 
data from the national registry of people with diabetes in Norway that is being developed 
might contribute to improving Norway’s standard of quality of foot care for people with 
diabetes. 
Improving the quality of foot care in community health care. An intervention study might 
contribute to enhancing the prevention of foot ulcers in diabetes care. Updated knowledge 
and intersectoral collaboration are necessary so that health care personnel can detect 
susceptibility to diabetes-related foot ulcers among community-dwelling people with 
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diabetes. An intervention study that combines intersectoral collaboration between all levels 
of care with updated knowledge concerning diabetes may facilitate the delivery of high-
quality health care [78, 120].  
 48
8. Conclusions 
The issues investigated in this study cover a broad range, which hopefully will contribute to 
the knowledge base concerning people with diabetes in the general population. Major 
findings from our study include: 
• Overall, 1 out of 10 community-dwelling people with diabetes reported a HFU. 
• The characteristics associated with a HFU were male gender, older than 75 years, 
height above the median (gender specific), insulin use and the presence of 
macrovascular complications.  
• Reported regular preventive foot care strategies are associated with female gender, 
insulin use and diabetes duration of more than 10 years. Further, those reporting 
macrovascular complications were less likely to report regular preventive diabetes 
foot care.  
• Reporting a HFU among people with diabetes is associated with poorer perceived 
health in everyday life. However, a HFU among people with diabetes was not 
associated with more anxiety or depression symptoms or poorer psychological well-
being. 
• Among people with diabetes those reporting a HFU had an excess mortality risk of 
about 40 % which was explained only partly by older age, sex (male), a higher 
HbA1c, current smoking, insulin use, microalbuminuria, cardiovascular disease and 
depression. 
• Our findings indicate the importance of identifying and closely following up of 
people with foot ulcers at an early stage and suggest that systematically 
implementing evidence-based guidelines in diabetes care and foot care may be very 
important for those with a HFU who are particularly susceptible to new ulcers and 
other adverse outcomes.  
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